FDA official logo
GSRS logo
PFDA official logo

LINAGLIPTIN

  • UNII: 3X29ZEJ4R2
  • Formula: C25H28N8O2
  • Preferred Substance Name: LINAGLIPTIN
  • InChIKey: LTXREWYXXSTFRX-QGZVFWFLSA-N

  • 668270-12-0
  • (R)-8-(3-AMINO-PIPERIDIN-1-YL)-7-BUT-2-YNYL-3-METHYL-1-(4-METHYL-QUINAZOLIN-2-YLMETHYL)-3,7-DIHYDRO-PURINE-2,6-DIONE
  • 1H-PURINE-2,6-DIONE, 8-((3R)-3-AMINO-1-PIPERIDINYL)-7-(2-BUTYNYL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2- QUINAZOLINYL)METHYL)-
  • 8-((3R)-3-AMINOPIPERIDIN-1-YL)-7-(BUT-2-YN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE
  • BI 1356
  • BI 1356 BS
  • BI-1356
  • BI-1356BS
  • BI-1356-BS
  • BS 1356 BS
  • BS-1356-BS
  • GLYXAMBI COMPONENT LINAGLIPTIN
  • JENTADUETO COMPONENT OF LINAGLIPTIN
  • LINAGLIPTIN [INN]
  • LINAGLIPTIN [JAN]
  • LINAGLIPTIN [MART.]
  • LINAGLIPTIN [MI]
  • LINAGLIPTIN [ORANGE BOOK]
  • LINAGLIPTIN [USAN]
  • LINAGLIPTIN [VANDF]
  • LINAGLIPTIN [WHO-DD]
  • LINAGLIPTIN COMPONENT OF GLYXAMBI
  • LINAGLIPTIN COMPONENT OF JENTADUETO
  • LINAGLIPTIN COMPONENT OF TRIJARDY XR
  • TRAJENTA
  • TRAZENTA
  • TRIJARDY XR COMPONENT LINAGLIPTIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.